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INTRODUCTION
The capacity of stem cells to express multipotentiality in
differentiation and self-renewal properties has been well esta-
blished in cells from many organs, but particularly the hema-
topoietic system (1). This is also true of cells from the central
nervous system (2). In recent years, there has been an increas-
ed interest in the development of adult tissue-derived mul-
tipotent stem cells for the treatment of human diseases, rather
than those of the fertilized ovum or early totipotent or blas-
tocyst-derived embryonic stem cells (3). The potential use of
totipotent or embryonic stem cells presents a variety of ethi-
cal problems.
The presence of neural stem cells (NSCs) has already been
reported in the mammalian embryonic cerebral cortex. These
cells are capable of producing three principal cell types of the
central nervous system (CNS); neurons, astrocytes and oligo-
dendrocytes (4). These precursor cells, generally located in the
subventricular zone (SVZ), have also been identified in adult
rat and human brains (4, 5). Multiple physiologic factors, such
as growth factors, cytokines and adhesion molecules, have been
shown to be involved in intrinsic and extrinsic control of NSCs’
self-renewal and differentiation (6). Research applications uti-
lizing NSCs are focused mainly on identification of inductive
factors and mediators in human neurogenesis, the determina-
tion of gene function in neuronal and glial differentiation, the
modeling of neurodegeneration, pharmaceutical discovery,
and gene or cell replacement therapy (2, 7, 8). Recently, in
vitro neurotoxicity studies using NSCs instead of neuronal
cell cultures have been reported (9, 10). 
In a previous study, a glial precursor cell line, designated
as B2 cells, was generated from primary cultures of oligoden-
drocytes/astrocytes isolated from an adult mouse brain (11). 
Using our established B2 cells, we performed the present
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Neurotoxicity Screening in a Multipotent Neural Stem Cell Line 
Established from the Mouse Brain
Neural stem cells (NSCs) have mainly been applied to neurodegeneration in some
medically intractable neurologic diseases. In this study, we established a novel NSC
line and investigated the cytotoxic responses of NSCs to exogenous neurotoxicants,
glutamates and reactive oxygen species (ROS). A multipotent NSC line, B2A1 cells,
was established from long-term primary cultures of oligodendrocyte-enriched cells
from an adult BALB/c mouse brain. B2A1 cells could be differentiated into neuronal,
astrocytic and oligodendroglial lineages. The cells also expressed genotypic mRNA
messages for both neural progenitor cells and differentiated neuronoglial cells. B2A1
cells treated with hydrogen peroxide and L-buthionine-(S,R)-sulfoximine underwent
30-40% cell death, while B2A1 cells treated with glutamate and kainate showed 25-
35% cell death. Cytopathologic changes consisting of swollen cell bodies, loss of
cytoplasmic processes, and nuclear chromatin disintegration, developed after expo-
sure to both ROS and excitotoxic chemicals. These results suggest that B2A1 cells
may be useful in the study of NSC biology and may constitute an effective neuro-
toxicity screening system for ROS and excitotoxic chemicals. 
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study to establish a clonal NSC line and investigate whether
the cells were useful for in vitro neurotoxicity screening tests
previously limited to neuronal cell cultures. 
MATERIALS AND METHODS
Generation of a B2A1 neural stem cell line
B2 cells selected from undifferentiated cell clusters present
in oligodendrocyte-enriched cultures were used as parent cells,
and were prepared from whole brains of 12-week-old BALB/c
mice. The detailed methods for selecting B2 cells and their
characterization have been described previously (11). Briefly,
during the first week of culture, about 90% of the cells exhib-
it surface immunolabeling of galactocerebroside (GalC), a
cell type-specific marker for oligodendrocytes. After 4 weeks
in vitro, the proportion of oligodendrocytes in oligodendroyte-
enriched cultures is reduced to 40-60%. Non-oligodendro-
glial cells, including 10-20% glial fibrillary acidic protein
(GFAP)-positive astrocytes, and 30-40% small bipolar cells
morphologically distinct from oligodendrocytes or astrocytes,
populate the cultures. These small bipolar cells aggregate each
other, and form a cell cluster or sphere, and have 8 mm cell
bodies and 20-30 mm cell processes. The cells are harvested
by a brief treatment for 10 min with phosphate buffered saline
(PBS) containing 0.1% trypsin and 1 mM ethylenediaminete-
traacetic acid (EDTA). They are then suspended in culture
medium, and replated into T75 culture flasks. After 3 months
with 6 serial passages, the culture consisted of a morpholog-
ically homogeneous cell population, designated as B2 cells.
They were further maintained for 6 months with 25 serial
passages in a culture medium, containing 10% horse serum
(HS). The identity of mouse-derived cells was verified by kary-
otype analysis with G-banding technique (12). The total chro-
mosome number of B2 cells was 40, which is identical to
normal somatic cells of BALB/c mice. 
B2 cell cultures were dissociated into single cells, suspend-
ed in 10% HS-containing medium, and plated in the absence
of feeder cells in a 96-well microtiter plate at a density of one
cell/well. The medium was renewed by half once per week.
After three weeks, well-separated colonies were picked for
further expansion. This procedure was repeated once more.
Only one out of the 28 clones, designated as B2A1, success-
fully generated and expanded. Stock cultures of B2A1 cells
were grown in 75 cm2 tissue culture flasks in the serum-free
chemically defined medium DM4 supplemented with 10%
fetal bovine serum (FBS) (13). The DM4 medium consisted
of Dulbecco’s modified Eagle’s medium (DMEM) supplement-
ed with 10 mg/mL insulin, 10 mg/mL of transferrin, 0.3 nM
of triiodothyronine, 30 nM of sodium selenite and 50 nM of
hydrocortisone. All chemicals described above, except for in-
sulin (Novo Laboratories, Willowdale, ON, Canada), were
obtained from Sigma (St. Louis, MO, USA). Cultures were
maintained at 37℃ in a humidified incubator containing
5% CO2, and the cells were passed once a week.
Characterization of B2A1 cells by immunocytochemistry
For immunocytochemical studies, B2A1 cells were plated
on poly-L-lysine (PL)-coated 9 mm round Aclar coverslips at
a density of 1×104 cells/coverslip. The cells were also cultur-
ed in the medium for five days, fixed in cold acid alcohol (5%
acetic acid in 95% ethanol) for 15 min at -20℃, and incu-
bated with normal goat serum for 20 min at room tempera-
ture (then processed for immunocytochemistry). To identify
neural cell phenotypes, cell cultures were processed for immu-
nostaining using cell type-specific markers: nestin for neural
stem cells; low molecular weight neurofilament protein (NF-
L) and b tubulin III for neurons; GFAP for astrocytes; GalC
and myelin basic protein (MBP) for oligodendrocytes; and,
Ricinus communis agglutinin-1 lectin (RCA-1) for microglia.
The cultures were incubated with primary antibodies, follow-
ed by biotinylated secondary antibodies and avidin-biotin
complex (ABC, Vector, Burlingame, CA, USA) and visual-
ized with 3-amino-9-ethyl carbazole chromogen (AEC, Sigma).
The antibodies utilized for immunochemical characterization
of neural cell types are listed in Table 1.
Neuronoglial differentiation of B2A1 cells by growth factors 
To investigate effects upon neural cell differentiation by
NF-L, low molecular weight neurofilament protein; GFAP, glial fibrillary acidic protein; GalC, galactocerebroside; MBP, myelin basic protein; RCA-1, Ricinus
communis agglutinin-1 lectin.
Antigen Specificity Clone name Subtype Dilution Supplier
Nestin Neural stem cell rat-401 Mouse IgG1 1:100 Chemicon
NF-L Neuron DA2 Mouse IgG1 1:200 Chemicon
b tubulin III Neuron SDL.3D10 MAb IgG1 1:100 Sigma
GFAP Astrocyte 6F2 Mouse IgG1 1:500 DAKO
GalC Oligodendrocyte mGalC Mouse IgG3 1:100 Chemicon
MBP Oligodendrocyte Polyclonal Rabbit Ig 1:100 DAKO
RCA-1 Microglia Lectin 1:100 Sigma
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various growth factors and pharmacological agents in B2A1
cells, the cells were plated on PL-coated coverslips at a den-
sity of 1×104 cells/coverslip. They were incubated for 72 hr
in DMEM (DM4), with triiodothyronine and hydrocortisone
supplement, in the presence of one of the following: 10% FBS,
with various mixtures of 10 mg/mL of insulin, 10 mg/mL
of transferrin, 30 nM selenite (ITS) (Sigma), 1mM dibutyryl
cyclic AMP (dbcAMP) (Sigma), 10 mM retinoic acid (RA)
(Sigma), 100 ng/mL of recombinant human basic fibroblast
growth factor (bFGF) (GIBCO BRL, Gaithersburg, MD, USA),
100 ng/mL of recombinant human platelet-derived growth
factor (PDGF) AA (Upstate Biotechnology, Lake Placid, NY,
USA), 10 ng/mL of leukocyte inhibitory factor (LIF, Sigma)
or 100 nM phorbol 12-myristate 13-acetate (PMA, Sigma).
The immunocytochemical stains for nestin, b tubulin III,
GFAP and GalC were processed from the cultures as describ-
ed above. 
For reverase transcriptase-polymerase chain reaction (RT-
PCR) analysis, B2A1 cells were plated on 6 well plates at a
density of 5×105 cells/well and incubated for 5 days in DM4
with addition of one of the above cytokines. RT-PCR was per-
formed in the cells harvested from each well using the oligonu-
cleotide primers listed in Table 2 (14, 15). The expression of
nestin, Notch1, and platelet-derived growth factor receptor-a
(PDGFR-a) for neural stem cell markers were determined.
To confirm the neuronal property of B2A1 cells, complemen-
tary DNA (cDNA) was amplified 35 PCR cycles for NF-L.
In addition, we looked for other CNS cell type markers, GFAP
for astrocytes, and MBP for oligodendrocytes. Glyceraldehyde-
3-phosphate dehydrogenase (G3PDH) was used as a reaction
standard. Total RNA was extracted from each sample using
TRIzol reagent (GIBCO-BRL). cDNA templates from each
sample were prepared from 2 mg of total RNA primed with
oligo dT primers (Pharmacia, Gaithersberg, MD, USA) using
400 units of Moloney murine leukemia virus (MMLV) reverse
transcriptase (GIBCO-BRL) followed by 35-40 PCR ampli-
fication cycles (94℃for 30 sec, annealing at 55℃for 60 sec
and extension at 72℃for 90 sec). Ten microliters of each PCR
product were analyzed by 1.5% agarose gel electrophoresis.
Authenticity of bands was determined by selective enzyme
digestion. 
Treatment with oxygen radicals and excitotoxic chemicals
For toxicity studies, B2A1 cells were seeded on both Aclar
coverslips and 96-well plates at a density of 1×104 cells per
coverslip or well in DMEM containing 10% fetal bovine serum,
5 mg/mL glucose, 25 mg/mL of gentamicin, and 2.5 mg/mL
of amphotericin B, and cultured for 7 days. The cultures were
changed to a medium containing no fetal bovine serum 24 hr
prior to cytotoxic treatment, and cells were exposed to the
chemicals for an additional 24 hr. All chemicals were pur-
chased from Sigma and the concentrations used for treatment
were: glutamate (20 mM-2 mM), kainate (20 mM-2 mM),
hydrogen peroxide (H2O2, 100 mM-1 mM), and buthionine
sulfoximine (BSO) (1-100 mM).
Cytotoxicity assay
Cytotoxicity was evaluated by cytopathologic changes and
cell viability of B2A1 cells after treatment with exogenous
ROS and excitotoxic chemicals. Cytopathologic features of
B2A1 cells on Aclar coverslips were examined using a phase-
contrast inverted microscope.
In order to measure viability of the B2A1 cells, the 3-(4,
5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) colorimetric assay was performed (16). This method
is based on the cellular reduction of tetrazolium salt MTT
(Sigma) by the mitochondrial dehydrogenase of viable cells,
which results in formation of a blue formazan product which
can then be measured with a spectrophotometer. In brief, MTT
was dissolved in DMEM at a concentration of 5 mg/mL, fil-
tered through a membrane filter (45 mm in diameter), and
stored at 4℃ in an aluminum foil-sealed tube. Following
addition of MTT stock solution into the cultures in 96 well
plates (10 mL per 100 mL medium), the cultures were incu-
bated for 4 hr at 37℃. A portion of the MTT was converted
to an insoluble bluish purple formazan by cleavage of the tetra-
zolium ring by cellular dehydrogenase enzymes. The medi-
um was removed, and the formazan product was dissolved
with 100 mL of acid-isopropanol (0.04N hydrochloride in iso-
propanol) per well. Optical density was measured using an
ELISA plate-reader at a wave length of 570 nm. The test was
repeated five times. Statistical analysis was done using a one
way ANOVA, followed by Dunnett’s multiple comparison
test. The level of significance was set at P<0.05. All statisti-
cal analyses were conducted by the SPSS 15.0 statistical soft-
ware program (SPSS 15.0, Chicago, IL, USA). 
Genes
Sequences 
(Sense and Antisense)
Product 
size (bp)
Nestin 5′ -AGT GTG AAG GCA AAG ATA GC-3′ 317
5′ -TCT GTC AGG ATT GGG ATG GG-3′
Notch1 5′ -TCA AGG CCC GGA GGA AGA AGT C-3′ 976
5′ -TCA GGG GAT GGG GTG AGG AAG-3′
PDGFRa 5′ -CTG TAA CTG GCA GGC TCG GAG-3′ 331
5′ -GTT GTC TGC AGT ACA AGT TGG CG-3′
NF-L 5′ -TCC TAC TAC ACC AGC CAT GT-3′ 284
5′ -TCC CCA GCA CCT TCA ACT TT-3′
GFAP 5′ -GCA GAG ATG ATG GAG CTC AAT GAC C-3′266
5′ -GTT TCA TCC TGG AGC TTC TGC CTC A-3′
MBP 5′ -ACA CGG GCA TCC TTG ACT CCA TCG G-3′510
5′ -TCC GGA ACC AGG TGG GTT TTC AGC G-3′
G3PDH 5′ -CCA TGT TCG TCA TGG GTG TGA ACC A-3′ 251
5′ -GCC AGT AGA GGC AGG GAT GAT GTT C-3′
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RESULTS
Phenotypes of B2A1 cells by immunocytochemistry
In serum-free DM4 medium, B2A1 cells were expressed as
either bipolar or tripolar cells with a 7-8 mm cell body size.
They had a tendency to grow individually or to aggregate
into small clumps (Fig. 1A). Nestin immunopositivity was
97.5% in the cells (Fig. 1B).
A limited number of cells expressed cell type specific mark-
ers for neurons, such as NF-L (2.1%) and btubulin III (1.9%)
(Fig. 1C). In addition, other CNS cell markers, including GFAP
(astrocyte marker), and GalC and MBP (oligodendrocyte mark-
ers) were positive using immunocytochemistry in 2.9%, 2.3%,
and 1.7% of the cells, respectively (Fig. 1D). RCA-1 as a mic-
roglial marker had no immunoreactivity in the cells. The above
immunoreactivities for CNS cell type specific markers are
summarized in Table 3. 
Neuronoglial cell differentiation of B2A1 cells by growth
factor treatment 
Cells reacting positively for nestin, b tubulin III, GFAP
and GalC per total B2A1 cells following incubation in DM4
serum-free medium, treated with serum or various growth
factors, are presented in Table 3. When incubated in 10%
FBS, ITS, dbcAMP, bFGF, PDGF, LIF or PMA-containing
culture medium, immunoreactivity for nestin was positive
in 85.4-95.8% of B2A1 cells (Fig. 2A). The proportion of
nestin positive cells decreased in RA-containing culture medi-
um (84.7%), while b tubulin III positive cells were signifi-
cantly increased (15.6%) (P<0.05). When treated with PDGF,
10% FBS, dbcAMP, RA or bFGF, btubulin III was expressed
in fewer cells (2.1-2.8%). Only a few cells were positive for
b tubulin III (less than 0.5%) in ITS, LIF, or PMA treated
culture medium (Fig. 2B). 
When incubated in dbcAMP or PDGF-containing culture
medium, GFAP immunolabeling was seen in 14.3-16.0%
of B2A1 cells, while 10% FBS, ITS, RA, bFGF or LIF-con-
taining medium was expressed in just 2.2-7.1% (P<0.01).
Immunopositivity for GFAP was seen in 2.2% of B2A1 cells
cultured in PMA-containing medium (Fig. 2C). When cul-
tured in 10% cAMP or PDGF-containing medium, GalC
positive cells were seen in 7.3-8.9% of B2A1 cells, while only
2.9-5.8% of the cells were positive in 10% FBS, RA, ITS,
bFGF, or PMA-containing medium (P<0.05) (Fig. 2D).
Fig. 1. Cytologic characteristics of B2A1 cells include bi- or tripolar cells (A, phase contrast microscopy), which are immunopositive for
nestin (B), b tubulin III (C), and GFAP (D) (×200).
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Genotypic expressions of B2A1 cells by cytokine treatment 
To determine whether B2A1 cells can express markers of
neural stem cells, as well as of early differentiating neurons,
astrocytes and oligodendrocytes, RT-PCR was performed in
cultured cells treated with various cytokines. Expression lev-
els were compared with the control expression of the house-
keeping gene G3PDH, and the data are summarized in Fig.
3. Stem cell or early precursor cell markers of CNS origin (nes-
tin, Notch1, PDGFR-a), neuronal markers for NF-L, astro-
cytic markers for GFAP, and oligodendroglial markers for
MBP, were consistently expressed. Even though the intensi-
ty of expression demonstrated some variation using treated
serum or growth factors, the expression of genotypic mark-
ers correlated relatively well with immunocytochemical phe-
notypes. 
Cytopathologic features of B2A1 cells exposed to ROS
and excitotoxic chemicals 
Compared with control cells (Fig. 4A), swelling of cell bodies
was the initial common cytopathologic hallmark in B2A1 cells
treated with the cytotoxic chemicals for 4-6 hr. This was follow-
ed by fragmentation and loss of neurites, loss of cell to cell con-
tact. Nuclear homogenization was then seen during the longer
incubation time of 24 hr. Cells treated with H2O2 (500 mM)
or BSO (1-100 mM) developed swelling of cell bodies with
Numbers are percentage of identified cells per total cells in culture.
-, negative immunoreactivity; NF-L, low molecular weight neurofilament
protein; GFAP, glial fibrillary acidic protein; GalC, galactocerebroside; MBP,
myelin basic protein; RCA-1, Ricinus communis agglutinin-1 lectin.
Ag/B2A1 
cells
DM4 FBS RA bFGF PDGF dbcAMP
Nestin 97.5 95.8 88.7 84.7 87.6 86.8
NF-L 2.1 2.5 3.4 14.8 2.8 2.6
b tubulin III 1.9 2.6 2.1 15.6 2.4 2.8
GFAP 2.9 7.1 16.0 6.9 4.3 14.3
GalC 2.3 5.7 7.3 4.7 3.1 8.9
MBP 1.7 2.2 5.1 2.0 3.3 4.8
RCA-1 -- - ---
Table 3. Immunocytochemical differentiation of B2A1 cells in
DM4 medium supplemented with 10% fetal bovine serum or
other growth factors
Fig. 2. Multipotential differentiation of B2A1 cells by treatment with growth factors. Most cells were immunopositive for nestin in any culture
condition (A). Cells immunopositive for b tubulin III significantly increased in RA-containing media (B), while GFAP (C) and GalC (D) positive
cells increased markedly in c-AMP or PDGF-containing media.
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focally expanding parts of cytoplasmic process (axon hillocks),
vacuolar changes with increased granularity of cytoplasm and
cytoplasmic processes (neuritis) (Fig. 4B), and progressive disin-
tegration of the nuclear chromatin (Fig. 4C). Glutamate or
kainate-treated cells (20-2,000 mM) also showed swelling of
cell bodies at 4-6 hr; however, swelling was limited to the cyto-
plasm of the cells and was more homogenous when compared
with H2O2 or BSO-treated cells. As time increased, the nucle-
ar chromatin and cytoplasm of the cells also disintegrated,
and dead cells formed homogenous round bodies (Fig. 4D). 
Cytotoxic response in B2A1 cells exposed to ROS and
excytotoxic chemicals 
In order to investigate the relationship of H2O2 exposure
to B2A1 cell death, the concentration of H2O2 which induces
cell death was measured using the MTT test (Fig. 5). There
was no significant cell death seen 24 hr after treatment with
1-100 mM H2O2 (Fig. 5A). However, viable cells were signif-
icantly reduced 24 hr after the addition of 500 mM H2O2(67.7
±2.6%) and 1 mM BSO (65.6±2.9%) (P<0.01 compared
to control cultures). Viable cells were also reduced to 61.3-
65.6% 24 hr after treatment with 1-100 mM BSO (Fig. 5B).
In 20-2,000 mM glutamate or kainate group treated for 24 hr,
viable cells were decreased to 66.6-74.4% (Fig. 5C, D) (P<
Fig. 3. Gene expression of cell type specific markers studied by
RT-PCR in B2A1 cells. The cells expressed both neural progeni-
tor cell markers (nestin, Notch1, PDGFR-a) and differentiated cell
markers for neurons (NF-L), astrocytes (GFAP), and oligodendro-
cytes (MBP). The expression levels vary depending upon the level
of growth factors added.
Nestin
Notch1
PDGFR-a
NF-L
GFAP
MBP
G3PDH
10% HS
ITS cAMP
RA bFGF
PDGF
LIF PMA
Fig. 4. Cytopathologic features of B2A1 cells. Compared with the control cells (A), cells treated with BSO (10 mM) show swelling of cell bod-
ies with axon hillocks, vacuolar changes with increased granularity of the cytoplasm at 4 hr (B), loss of neurites, progressive disintegration
of nuclear chromatin with homogenization, and loss of cell to cell contact at 24 hr (C). Glutamate or kainate-treated cells (20 mM) also show
swelling of cell bodies and loss of neurites at 12 hr (D) (×200). 
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0.01 compared to control cultures). A dose-response pattern
of cell death was not present in the BSO, glutamate or kainate
treated groups in this experiment. 
DISCUSSION 
In this study, an NSC line designated as B2A1 was gener-
ated from isolated adult mouse brain cells by use of a long
term, two-step culture process. The first step generated B2
cells from primary cultures of oligodendrocyte-enriched frac-
tions. The B2 cells were immunopositive for vimentin, the
major intermediate filament protein of immature neuroec-
todermal cells (17). The B2 cells did not express any cell type-
specific markers for neuronal, microglial, or endothelial cells.
When cultured in the presence of dbcAMP, cells were im-
munopositive for vimentin, GFAP, O4, and GalC. These im-
munocytochemical features suggest that B2 cells were com-
posed of glial precursor cells mixed with immature neuroec-
todermal cells.
The second step in development generated B2A1 cells from
focal aggregates of B2 cells using limited dilution. The B2A1
cells demonstrated several characteristics of neural stem cells
in the following aspects. 
First, most of the cells (95.7%) were immunopositive for
nestin, an intermediate filament protein specifically express-
ed in NSCs from murine CNS (18). Second, B2A1 cells main-
tained NSC markers, and could differentiate into neurons,
astrocytes and oligodendrocytes when cultured in the pres-
ence of growth factors, such as ITS, dbcAMP, RA, bFGF,
PDGF, LIF, and PMA. Neuronal differentiation was markedly
increased in the presence of RA. Astrocytic differentiation sig-
nificantly increased with the addition of dbcAMP and PDGF,
while oligodendrocytes were increased by PDGF treatment.
These immunocytochemical features suggest that B2A1 cells
have the multipotentiality for differentiating into cells of the
CNS. Third, genotypic expression of B2A1 cells as seen with
RT-PCR analysis demonstrates mRNA for nestin, Notch1,
and PDGFR-a, all of which are genomic markers for undif-
ferentiated neuroepithelial cells (18-20). Forth, other differ-
entiated neural cell mRNAs, such as NF-L, GFAP, and MBP,
were identified in B2A1 cells. There was a good correlation
between mRNA expressions seen with RT-PCR and the im-
munocytochemical features noted in this study.
Fig. 5. Effect of H2O2 (A), BSO (B), glutamate (C) and kainate (D) treatment for 24 hr, measured by the MTT test. Data are shown as mean
±standard deviation. The number of viable cells are significantly decreased after the addition of 500 mM H2O2 along the stepwise increase
of doses. However, a dose-response pattern is not observed in the BSO, glutamate, or kainite treated groups.
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Recent molecular genetic studies show that a number of
molecules are expressed in the early stages of embryonic neu-
ral development. These include transcription factors, such as
Brain1 (Brn1), Numb, NeuroD, and downstream effectors
of Notch1, Hes1, and Presenilin (18-22). Notch1 is express-
ed in progenitor cells within the subventricular zone in mice,
suggesting that there is a biologic role in both progenitor cell
proliferation and neuronal differentiation during mammalian
cortical neurogenesis (21). PDGFR-a expression has primar-
ily been described in oligodendrocyte precursors during early
CNS development (20). In a recent study, PDGFR-awas iden-
tified in neuroepithelial cells of the neural plate at day 8.5 in
embryonic mice, as well as in developing granule cells in the
postnatal cerebellum, in Purkinje cells in the adult cerebel-
lum and on the processes of developing dorsal root ganglion
cells (20). These observations suggest that PDGFR-a is anoth-
er marker of undifferentiated cells, which are subsequently
able to differentiate into neurons and glial cells. When B2A1
cells were cultured in PDGF in this study, increased fraction
of differentiated neurons, astrocytes, and oligodendrocytes
were identified. The cytologic differentiation of B2A1 cells
might thus be due to PDGFR-a. 
In order to study stem cells at any level, one must be able
to purify, or at least enrich for, stem cells from the target tis-
sue or organ. One method of enriching for particular cell types
is by use of fluorescence-activated cell sorting (FACS) or mag-
netic-activated cell sorting (MACS) (23). These techniques
rely on the ability of antibodies to bind to proteins express-
ed on the cell surface, and they have commonly been used
to isolate hematopoietic stem cells (HSC). Another method
used to isolate stem cells is with the use of long-term cell cul-
ture, which was applied in this study to generate an NSC line
(24). Briefly, whole cell populations are isolated from the tis-
sue of interest and then grown in cultures which are conducive
to the proliferation of stem cells and the maintenance of stem
cell characteristics. This method has been used both for the
purification of NSCs and of mesenchymal stem cells (MSCs). 
There have been a few studies concerning the generation
of multipotent neural stem cells in mice. A CNS-derived,
conditionally immortalized, neural progenitor cell line (CINP)
was generated to make nerve growth factor (NGF)-secreting
cells using a retroviral vector (25). Other NSCs have been
purified from adult mouse brain by flow cytometry, and used
to study their functional ability to generate neural and non-
neural cells (26). Another multipotent neural progenitor cell
(2Y6f1) has been cloned from the cerebellum of an adult p53-/-
mouse (27). The B2A1 cells used in our studies reported here
were established from long term primary cultures derived from
BALB/c adult mice brains maintained within normal physi-
ologic conditions. This has supported development of a new
cell line useful for the study of neural stem cell biology. 
In the biochemical process that leads to neuronal cell death,
ROS (superoxide, hydroxyl radical and hydrogen peroxide)
and the excitatory neurotransmitter glutamate have been
shown to have a relation to major neurological diseases, such
as stroke, epilepsy, trauma, and neurodegeneration (28). This
present study revealed levels of 25-30% cell death in B2A1
cultures that were treated with 20-2,000 mM glutamate or
kainite for 24 hr, compared to control groups. High concen-
trations of glutamate (10 mM or more) has been known to
be a major contributing mechanism for causing neuronal dam-
age in the CNS, due to disruption of normal intracellular oxy-
gen radical homeostasis. Under conditions such as cerebral
ischemia, extracellular glutamate levels increase 8 fold, which
results in a marked decrease in brain GSH levels due to the
blocking of cystine uptake (29). 
In addition to excitotoxic cell death in B2A1 cells, cell death
from H2O2 and BSO was established in this study. B2A1 cell
death occurred in a dose-dependent manner in cultures treat-
ed with more than 100 mM H2O2, whereas rates of 30-35%
cell death occurred in 1-100 mM BSO. It is generally accept-
ed that BSO is an irreversible inhibitor of glutathione syn-
thase. The cytotoxic effect of BSO in B2A1 cells treated for
24 hr might be related to decreases in GSH synthesis.
There were no significant differences seen between excito-
toxic and ROS injury in the cytopathologic changes of B2A1
cells. Cells treated with glutamate or kainate, develop a swollen
cell body with loss of neurites, and then nuclear disintegra-
tion is noted. However, the cells treated with H2O2 or BSO
display swelling of the cell body and neurites, with vacuole
formation. These cytopathologic features suggest that exci-
totoxic chemicals mainly act upon cell surface receptors, result-
ing in Ca2+ overload, while ROS mainly act by direct dam-
age to the cell membrane. Nevertheless, this speculation needs
to be clarified through further studies based on ultrastructural
or biochemical evidences. 
In summary, our present study demonstrates the establish-
ment of an NSC line which differentiates into neurons, astro-
cytes, and oligodendrocytes following treatment with growth
factors. Cytotoxic cell death due to ROS and excitotoxic chem-
icals occurred. These data strongly suggest that B2A1 cells
might be useful both for the neurobiologic study of NSC and
as a neurotoxicity screening system utilizing primary neuronal
cultures of the CNS. 
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